Methyl 2-methyl-2-(4-nitrophenyl)propanoate, 97%, 5g

Ethyl3-bromo-6,6-difluoro-5,7-dihydropyrazolo[5,1-b][1,3]oxazine-2-carboxylate, 98%, 500mg

(2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoic acid hydrate, 95.0%, 5g

4-Phenylbutane-1-sulfonamide, 95%, 100mg

(S)-2-methylpiperidine-2-carboxylic acid, 95%, 250mg

Terpènes d'orange, purs, 2,5 l, emballage en verre

(R)-4-(tert-Butyl)-2-(1,8-naphthyridin-2-yl)-4,5-dihydrooxazole, 97%, 250mg

1-(7-Chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carboxylic acid, 97%, 100mg

H-Tyr(3-l)-OH, 95%, 10g

5-Bromo-2,4-dimethoxypyrimidine, 97.0%, 5g

(S)-1-Boc-Azetidine-2-carboxylic acid, 97.0%, 1g

Sodium 1-Nonanesulfonate>98.0%(T)25g

(tert-Butoxycarbonyl)-D-homoserine>95.0%(T)(HPLC)5g